|
CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ) DCF -Bewertung
CN | Consumer Defensive | Packaged Foods | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ) Bundle
Als Investor oder Analyst dient der DCF-Taschenrechner des CSPC Innovation Pharmaceutical Co., Ltd. (300765SZ) als Ihre Anlaufstelle für eine genaue Bewertung. Mit realen Daten von CSPC Innovation Pharmaceutical können Sie Prognosen anpassen und die Auswirkungen sofort beobachten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,256.5 | 1,317.4 | 1,432.0 | 2,626.5 | 2,501.7 | 3,078.4 | 3,788.0 | 4,661.3 | 5,735.8 | 7,058.0 |
| Revenue Growth, % | 0 | 4.85 | 8.7 | 83.42 | -4.75 | 23.05 | 23.05 | 23.05 | 23.05 | 23.05 |
| EBITDA | 384.0 | 414.7 | 543.1 | 915.2 | 979.9 | 1,071.2 | 1,318.1 | 1,622.0 | 1,995.9 | 2,456.0 |
| EBITDA, % | 30.56 | 31.48 | 37.93 | 34.84 | 39.17 | 34.8 | 34.8 | 34.8 | 34.8 | 34.8 |
| Depreciation | 47.1 | 53.4 | 69.2 | 72.9 | 100.1 | 119.5 | 147.1 | 181.0 | 222.7 | 274.0 |
| Depreciation, % | 3.75 | 4.05 | 4.83 | 2.78 | 4 | 3.88 | 3.88 | 3.88 | 3.88 | 3.88 |
| EBIT | 336.9 | 361.2 | 474.0 | 842.2 | 879.8 | 951.7 | 1,171.0 | 1,441.0 | 1,773.2 | 2,181.9 |
| EBIT, % | 26.81 | 27.42 | 33.1 | 32.07 | 35.17 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 |
| Total Cash | 1,435.2 | 1,460.7 | 1,645.5 | 2,195.7 | 3,422.2 | 2,977.4 | 3,663.8 | 4,508.4 | 5,547.6 | 6,826.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 349.8 | 304.0 | 428.7 | 716.8 | 545.0 | 799.9 | 984.3 | 1,211.2 | 1,490.4 | 1,834.0 |
| Account Receivables, % | 27.84 | 23.07 | 29.93 | 27.29 | 21.79 | 25.98 | 25.98 | 25.98 | 25.98 | 25.98 |
| Inventories | 124.2 | 111.0 | 216.9 | 238.1 | 223.7 | 316.9 | 389.9 | 479.8 | 590.4 | 726.5 |
| Inventories, % | 9.89 | 8.43 | 15.14 | 9.07 | 8.94 | 10.29 | 10.29 | 10.29 | 10.29 | 10.29 |
| Accounts Payable | 92.7 | 64.2 | 129.2 | 178.7 | 173.7 | 215.6 | 265.3 | 326.4 | 401.7 | 494.3 |
| Accounts Payable, % | 7.38 | 4.87 | 9.02 | 6.81 | 6.94 | 7 | 7 | 7 | 7 | 7 |
| Capital Expenditure | -106.1 | -117.7 | -66.9 | -114.1 | -95.7 | -186.1 | -229.0 | -281.8 | -346.7 | -426.6 |
| Capital Expenditure, % | -8.44 | -8.94 | -4.67 | -4.34 | -3.83 | -6.04 | -6.04 | -6.04 | -6.04 | -6.04 |
| Tax Rate, % | 15.28 | 15.28 | 15.28 | 15.28 | 15.28 | 15.28 | 15.28 | 15.28 | 15.28 | 15.28 |
| EBITAT | 274.6 | 296.6 | 481.5 | 718.5 | 745.4 | 825.3 | 1,015.6 | 1,249.7 | 1,537.8 | 1,892.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -165.7 | 262.7 | 318.1 | 417.6 | 930.9 | 452.7 | 726.0 | 893.3 | 1,099.3 | 1,352.7 |
| WACC, % | 5.32 | 5.32 | 5.32 | 5.32 | 5.32 | 5.32 | 5.32 | 5.32 | 5.32 | 5.32 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 3,786.8 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 1,393 | |||||||||
| Terminal Value | 60,167 | |||||||||
| Present Terminal Value | 46,440 | |||||||||
| Enterprise Value | 50,227 | |||||||||
| Net Debt | -3,421 | |||||||||
| Equity Value | 53,648 | |||||||||
| Diluted Shares Outstanding, MM | 1,171 | |||||||||
| Equity Value Per Share | 45.83 |
What You Will Receive
- Authentic CSPC Financial Data: Preloaded with historical and projected figures for accurate analysis of CSPC Innovation Pharmaceutical Co., Ltd. (300765SZ).
- Customizable Template: Easily adjust critical inputs such as revenue growth, WACC, and EBITDA percentage.
- Instant Calculations: Watch the intrinsic value of CSPC update in real-time as you make modifications.
- Advanced Valuation Tool: Tailored for investors, analysts, and consultants aiming for reliable DCF results.
- Intuitive Interface: Designed with a straightforward layout and clear instructions suitable for all skill levels.
Key Features
- Real-Life CSPC Data: Pre-filled with historical financials and future projections for CSPC Innovation Pharmaceutical Co., Ltd. (300765SZ).
- Fully Customizable Inputs: Tailor revenue growth, margins, WACC, tax rates, and capital expenditures to fit your analysis needs.
- Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your customized inputs.
- Scenario Testing: Develop various forecasting scenarios to evaluate different valuation possibilities.
- User-Friendly Design: Intuitive and organized layout designed for both professionals and novices.
How It Functions
- Step 1: Download the ready-to-use Excel template featuring data for CSPC Innovation Pharmaceutical Co., Ltd. (300765SZ).
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth rate, profit margins).
- Step 4: View the updated results in real-time, including the intrinsic value of CSPC Innovation Pharmaceutical Co., Ltd. (300765SZ).
- Step 5: Use the outputs to make well-informed investment choices or create comprehensive reports.
Why Opt for This Calculator?
- Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and industry consultants.
- Comprehensive Data: CSPC Innovation Pharmaceutical Co., Ltd.'s (300765SZ) historical and projected financials preloaded for precise insights.
- Scenario Analysis: Effortlessly test various forecasts and assumptions.
- Transparent Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance to help you navigate the calculations.
Who Can Benefit from This Product?
- Pharmaceutical Students: Discover drug development processes and apply them to real-world case studies.
- Researchers: Integrate advanced models and methodologies into your studies related to CSPC Innovation Pharmaceutical Co., Ltd. (300765SZ).
- Investors: Evaluate your investment strategies by analyzing market trends and outcomes for CSPC Innovation Pharmaceutical Co., Ltd. (300765SZ).
- Market Analysts: Enhance your analysis with a customizable model tailored for pharmaceutical valuation.
- Entrepreneurs in Pharma: Understand how established companies like CSPC Innovation Pharmaceutical Co., Ltd. (300765SZ) are assessed in the market.
Contents of the Template
- Pre-Filled DCF Model: CSPC Innovation Pharmaceutical Co., Ltd.'s financial data ready for instant application.
- WACC Calculator: Comprehensive calculations for Weighted Average Cost of Capital.
- Financial Ratios: Assess CSPC’s profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, profit margins, and capital expenditures to suit your scenarios.
- Financial Statements: Annual and quarterly reports provided for in-depth analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.